Development and duration of human papillomavirus lesions, after initial infection

Journal of Infectious Diseases

Volumn 191, Issue 5, 2005, Pages 731-738

  Winer, Rachel L ^a   Kiviat, Nancy B ^a   Hughes, James P ^a   Adam, Diane E ^a   Lee, Shu Kuang ^a   Kuypers, Jane M ^a   Koutsky, Laura A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COLLEGE STUDENT; CONDYLOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; LONGITUDINAL STUDIES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 13944260766     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/427557     Document Type: Article

References (20)

1. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Incident infection with genital human papillomavirus: rates and risk factors among a cohort of female university students. Am J Epidemiol 2003; 157:218-26.
2. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357:1831-6.
3. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001; 285:2995-3002.
4. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-8.
5. Schiffman M, Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med 2003; 127:946-9.
6. Franceschi S, Clifford G, Plummer M. Prospects for primary prevention of cervical cancer in developing countries. Salud Publica Mex 2003; 45(Suppl 3):S430-6.
7. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347:1645-51.
8. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285:1500-5.
9. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 1994; 271:1866-9.
10. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84:1074-8.
11. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87:1365-71.
12. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective studv. Lancet 1999; 354:20-5.
13. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among ecologically normal women. J Infect Dis 1994; 169:235-40.
14. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327:1272-8.
15. Creagh T, Bridger JE, Kupek E, Fish DE, Martin-Bates E, Wilkins MJ. Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasia. J Clin Pathol 1995; 48:59-60.
16. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52:342-62.
17. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12:186-92.
18. Syrjanen K, Kataja V, Yliskoski M, Chang F, Syrjanen S, Saarikoski S. Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol 1992; 79:675-82.
19. Reis LAG, Miller GA, Hankey BF, Kosary CL, Harras A, Edwards BK. SEER cancer statistics review, 1973-1991: tables and graphs. National Institute of Health Publication 94-2789. Bethesda, MD: National Cancer Institute, 1994.
20. ASCUS-LSIL Triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003; 188:1393-400.